Marimed (MRMD) Profit After Tax (2011 - 2026)
Marimed (MRMD) posted quarterly Profit After Tax of -$3.8 million for Q1 2026, up 30.92% year-over-year from -$2.9 million in Q1 2025, and up 18.44% quarter-over-quarter from -$4.6 million in Q4 2025.
Marimed (MRMD) Profit After Tax (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Profit After Tax for 16 consecutive years, with -$3.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax rose 30.92% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$12.8 million (up 22.92% YoY), while the FY2025 annual figure was -$14.5 million, down 15.95% from the prior year.
- Profit After Tax grew to -$3.8 million in Q1 2026 per MRMD's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Profit After Tax topped out at $4.6 million in Q4 2022 and bottomed at -$10.2 million in Q4 2023.
- Historically, Profit After Tax has averaged -$2.0 million across 5 years, with a median of -$1.4 million in 2024.
- Annual changes were most pronounced in 2022 — Profit After Tax jumped 175.45% — and 2023, when it sank 320.63%.
- Marimed's Profit After Tax stood at $4.6 million in 2022, then slumped by 320.63% to -$10.2 million in 2023, then grew by 18.37% to -$8.3 million in 2024, then jumped by 44.09% to -$4.6 million in 2025, then rose by 18.44% to -$3.8 million in 2026.
- Business Quant data shows MRMD's Profit After Tax at -$3.8 million in Q1 2026, -$4.6 million in Q4 2025, and -$2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Marimed | 28.08 Mn | 17.74 Mn | 16.23 Mn | -3.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.59 Mn |
| Mar 31, 2026 | -3.79 Mn |
| Dec 31, 2025 | -4.64 Mn |
| Sep 30, 2025 | -2.95 Mn |
| Jun 30, 2025 | -1.40 Mn |
| Mar 31, 2025 | -5.48 Mn |
| Dec 31, 2024 | -8.30 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.78 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | -10.17 Mn |
| Sep 30, 2023 | -4.26 Mn |
| Jun 30, 2023 | -935,000.00 |
| Mar 31, 2023 | -664,000.00 |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 4.24 Mn |
| Dec 31, 2021 | -6.11 Mn |
| Sep 30, 2021 | 2.12 Mn |